CVS Health continues to outperform Novo Nordisk Class B by 77.6% year to date

Press/Media

PeriodApr 1 2025

Media coverage

5

Media coverage

  • TitleCVS Health continues to outperform Novo Nordisk Class B by 77.6% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date04/1/25
    PersonsShannon Lynch
  • TitleCVS Health continues to outperform Zoetis by 51.5% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date04/1/25
    PersonsShannon Lynch
  • TitleCVS Health continues to outperform Roche by 39.3% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date04/1/25
    PersonsShannon Lynch
  • TitleCVS Health continues to outperform Cencora by 29.1% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date04/1/25
    PersonsShannon Lynch
  • TitleCVS Health- 5 Reasons Investors Remain Bullish (and 4 Reasons Why Bearish)
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date04/1/25
    PersonsShannon Lynch